SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-328669
Filing Date
2013-08-09
Accepted
2013-08-09 12:43:51
Documents
17
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d544509d10q.htm 10-Q 750881
2 EX-10.1 d544509dex101.htm EX-10.1 42780
3 EX-10.2 d544509dex102.htm EX-10.2 8426
4 EX-10.3 d544509dex103.htm EX-10.3 13935
5 EX-31.1 d544509dex311.htm EX-31.1 10362
6 EX-31.2 d544509dex312.htm EX-31.2 10301
7 EX-32.1 d544509dex321.htm EX-32.1 4362
8 EX-32.2 d544509dex322.htm EX-32.2 4555
15 GRAPHIC g544509cm7.jpg GRAPHIC 59711
16 GRAPHIC g544509cm7a.jpg GRAPHIC 3079
17 GRAPHIC g544509cm9.jpg GRAPHIC 4256
  Complete submission text file 0001193125-13-328669.txt   5691162

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aegr-20130630.xml EX-101.INS 599656
10 XBRL TAXONOMY EXTENSION SCHEMA aegr-20130630.xsd EX-101.SCH 31753
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20130630_cal.xml EX-101.CAL 55484
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20130630_def.xml EX-101.DEF 63442
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20130630_lab.xml EX-101.LAB 241882
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20130630_pre.xml EX-101.PRE 162314
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 131025510
SIC: 2834 Pharmaceutical Preparations